Quick and enhanced diagnosis of cardiovascular diseases are expected to boost the growth of the global wearable ambulatory monitoring device market at a CAGR of 8.20% during the forecast period of 2022 to 2030

Market Research Future (MRFR) has published a cooked research report on the “Global Wearable Ambulatory Monitoring Device Market” that contains the information from 2022 to 200.

Market Highlights

The global wearable ambulatory monitoring device market is expected to register a CAGR of 8.14% during the forecast period and hit USD 4.17 Billion by 2030.

A wearable ambulatory monitoring device monitors the patient's heart rates and provide patient data to healthcare professionals through a wireless network. The key factors attributing to the market growth are increasing rate of cardiac diseases, demand for ambulatory monitoring devices, and the rising prevalence of wireless mobile cardiac monitoring devices and enhanced diagnostics. However, product recalls, complications related to devices, and increasing availability of counterfeit products are posing as threats to the growth of the market. Increasing investments in R&D for development of technologically advanced products creates an opportunity for the global wearable ambulatory monitoring device market to growth.

Key Players

MRFR recognizes the following companies as the key players in the global wearable ambulatory monitoring device market— General Electric Company (US), ACS Diagnostics (US), Koninklijke Philips NV (Netherlands), iRhythm Technologies, Inc. (US), Medicomp Inc. (US), Medtronic Plc (Ireland), Boston Scientific Corporation (US), G Medical Innovations (Israel), Hill-Rom Services Inc. (US) and Asahi Kasei Corporation (Japan).

Segment Analysis

The global wearable ambulatory monitoring device market has been divided based on product type.

Based on product type, the market has been segregated into cardiac event monitor, holter monitor, mobile cardiac telemetry device and implantable cardiac monitor. The Holter monitor segment held the largest market in 2020, owing to its longer assessment period and high adoption rate. The mobile cardiac telemetry devices segment is expected to witness the highest CAGR from 2022 to 2030.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Wearable Ambulatory Monitoring Device Market Research Report

Regional Analysis

The global wearable ambulatory monitoring device market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to dominate the market due to the presence of major manufacturers such as General Electric Company, iRhythm Technologies, and Boston Scientific Corporation, among others, increasing prevalence of cardiovascular diseases, acquisition, and new product launches to gain a substantial market share. Europe is likely to hold a significant share in the global wearable ambulatory monitoring device market. This can be attributed to recent healthcare developments, increasing disposable income per individual, increased healthcare spending, and governmental support for R&D. The Asia-Pacific region is anticipated to witness rapid growth rate owing to low manufacturing & labor cost, developing healthcare infrastructure, and growing geriatric population. The market in the Middle East & Africa is growing dramatically due to the increasing awareness among the population, demand for better treatments in countries, and rising disposable income.

Key Findings of the Study

• The global wearable ambulatory monitoring device market was evaluated at USD 3,797.08 million in 2020 and is projected to register a CAGR of 8.20% during the assessment period.


• The Americas accounted for the largest market share of 38.03% in 2020 and is anticipated to reach up to USD 2,221.07 million by 2027.


• Based on product type, the holter monitor segment held the largest market share with a value of USD 1,933.81 million in 2020.


• General Electric Company (US), ACS Diagnostics (US), Koninklijke Philips NV (Netherlands), iRhythm Technologies, Inc. (US) and Medicomp Inc. (US) are the key market players.